Literature DB >> 27689459

The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma.

Maryam Rahman1, Joseph Abbatematteo1, Edward K De Leo1, Paul S Kubilis1, Sasha Vaziri1, Frank Bova1, Elias Sayour1, Duane Mitchell1, Alfredo Quinones-Hinojosa2.   

Abstract

OBJECTIVE An increased extent of resection (EOR) has been shown to improve overall survival of patients with glioblastoma (GBM) but has the potential for causing a new postoperative neurological deficit. To investigate the impact of surgical neurological morbidity on survival, the authors performed a retrospective analysis of the clinical data from patients with GBM to quantify the impact of a new neurological deficit on the survival benefit achieved with an increased EOR. METHODS The data from all GBM patients who underwent resection at the University of Florida from 2010 to 2015 with postoperative imaging within 72 hours of surgery were included in the study. Retrospective analysis was performed on clinical outcomes and tumor volumes determined on postoperative and follow-up imaging examinations. RESULTS Overall, 115 patients met the inclusion criteria for the study. Tumor volume at the time of presentation was a median of 59 cm3 (enhanced on T1-weighted MRI scans). The mean EOR (± SD) was 94.2% ± 8.7% (range 59.9%-100%). Almost 30% of patients had a new postoperative neurological deficit, including motor weakness, sensory deficits, language difficulty, visual deficits, confusion, and ataxia. The neurological deficits had resolved in 41% of these patients on subsequent follow-up examinations. The median overall survival was 13.1 months (95% CI 10.9-15.2 months). Using a multipredictor Cox model, the authors observed that increased EOR was associated with improved survival except for patients with smaller tumor volumes (≤ 15 cm3). A residual volume of 2.5 cm3 or less predicted a favorable overall survival. Developing a postoperative neurological deficit significantly affected survival (9.2 months compared with 14.7 months, p = 0.02), even if the neurological deficit had resolved by the first follow-up. However, there was a trend of improved survival among patients with resolution of a neurological deficit by the first follow-up compared with patients with a permanent neurological deficit. Any survival benefit from achieving a 95% EOR was abrogated by the development of a new neurological deficit postoperatively. CONCLUSIONS Developing a new neurological deficit after resection of GBM is associated with a decrease in overall survival. A careful balance between EOR and neurological compromise needs to be taken into account to reduce the likelihood of neurological morbidity from surgery.

Entities:  

Keywords:  EOR = extent of resection; GBM = glioblastoma; HR = hazard ratio; HRQOL = health-related quality of life; KPS = Karnofsky Performance Scale; RV = residual volume; extent of resection; glioblastoma; iMRI = intraoperative MRI; neurological deficit; oncology; postoperative morbidity; quality of life; resection

Mesh:

Year:  2016        PMID: 27689459     DOI: 10.3171/2016.7.JNS16396

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  41 in total

1.  How many patients require brain mapping in an adult neuro-oncology service?

Authors:  Anastasios Giamouriadis; Jose Pedro Lavrador; Ranjeev Bhangoo; Keyoumars Ashkan; Francesco Vergani
Journal:  Neurosurg Rev       Date:  2019-05-19       Impact factor: 3.042

2.  Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.

Authors:  Federico Pessina; Pierina Navarria; Luca Cozzi; Anna Maria Ascolese; Matteo Simonelli; Armando Santoro; Elena Clerici; Marco Rossi; Marta Scorsetti; Lorenzo Bello
Journal:  J Neurooncol       Date:  2017-07-08       Impact factor: 4.130

Review 3.  Conventional and advanced imaging throughout the cycle of care of gliomas.

Authors:  Gilles Reuter; Martin Moïse; Wolfgang Roll; Didier Martin; Arnaud Lombard; Félix Scholtes; Walter Stummer; Eric Suero Molina
Journal:  Neurosurg Rev       Date:  2021-01-07       Impact factor: 3.042

4.  Commentary: The Effects of Postoperative Neurological Deficits on Survival in Patients With Single Brain Metastasis.

Authors:  Michael Zhang; Gordon Li
Journal:  Oper Neurosurg (Hagerstown)       Date:  2020-08-28       Impact factor: 2.703

5.  A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma.

Authors:  Christina Jackson; John Choi; Adham M Khalafallah; Carrie Price; Chetan Bettegowda; Michael Lim; Gary Gallia; Jon Weingart; Henry Brem; Debraj Mukherjee
Journal:  J Neurooncol       Date:  2020-06-19       Impact factor: 4.130

6.  What effects does awake craniotomy have on functional and survival outcomes for glioblastoma patients?

Authors:  Anne Clavreul; Ghislaine Aubin; Matthieu Delion; Jean-Michel Lemée; Aram Ter Minassian; Philippe Menei
Journal:  J Neurooncol       Date:  2021-01-04       Impact factor: 4.130

7.  Impact of removed tumor volume and location on patient outcome in glioblastoma.

Authors:  Al-Wala Awad; Michael Karsy; Nader Sanai; Robert Spetzler; Yue Zhang; Yizhe Xu; Mark A Mahan
Journal:  J Neurooncol       Date:  2017-07-06       Impact factor: 4.130

8.  AI-Assisted In Situ Detection of Human Glioma Infiltration Using a Novel Computational Method for Optical Coherence Tomography.

Authors:  Ronald M Juarez-Chambi; Carmen Kut; Jose J Rico-Jimenez; Kaisorn L Chaichana; Jiefeng Xi; Daniel U Campos-Delgado; Fausto J Rodriguez; Alfredo Quinones-Hinojosa; Xingde Li; Javier A Jo
Journal:  Clin Cancer Res       Date:  2019-07-17       Impact factor: 12.531

9.  Safety aspects of opioid-naïve patients with high-grade glioma treated with D,L-Methadone: an observational case series.

Authors:  Christian von der Brelie; Bawarjan Schatlo; Chistoph Bettag; Veit Rohde
Journal:  Neurosurg Rev       Date:  2020-02-14       Impact factor: 3.042

Review 10.  Intraoperative MRI for Brain Tumors.

Authors:  Cara Marie Rogers; Pamela S Jones; Jeffrey S Weinberg
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.